Business Context and Reporting Period
This Form 8-K is a current report filed by OncoCyte Corporation (noted as Insight Molecular Diagnostics Inc. in metadata) on November 13, 2018. The filing serves to announce the company's financial results for the three-month period ended September 30, 2018. The registrant is incorporated in California and identifies as an emerging growth company.
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release attached as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the body text. It directs readers to the attached press release for the results of operations and financial condition for the quarter ended September 30, 2018.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing includes a standard disclaimer regarding forward-looking statements (using terms like "may," "will," "believes," "plans"). It warns that actual results may differ materially due to factors outlined in the company's most recent Form 10-K and Form 10-Q under "Risk Factors."
- Outlook: No specific financial guidance or future outlook is provided in this text; the company disclaims any obligation to update forward-looking statements.
- Unusual Items: No unusual items are described in the filing text.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for the quarter ended September 30, 2018, by reviewing Exhibit 99.1 (the press release).
- Confirm the company's current cash position and runway, as these are not stated in the 8-K text.
- Review the "Risk Factors" section of the most recent Form 10-K or 10-Q to understand the specific contingencies mentioned in the forward-looking statement disclaimer.
- Check for any subsequent filings or updates regarding the company's operational status post-November 2018.